European Commission Approves Purchase Agreement Amendment for Valneva’s Inactivated COVID-19 Vaccine Read more
CAMP4 Secures $100 Million Series B Financing to Accelerate Expansion of its Novel Regulatory RNA-Targeting Platform and Advance Lead Programs into the Clinic Read more
Karyopharm Granted Regulatory Designations for Eltanexor for the Treatment of Myelodysplastic Syndromes Read more
ZyVersa Therapeutics to Become a Publicly Traded Biopharma Company via Merger with Larkspur Health Acquisition Corp. Read more
Expert speakers will discuss the CMC approaches to injectable device development, on the 3rd Annual Pre-Filled Syringes San Francisco Conference 2022 Read more
Sorrento Therapeutics Announces the FDA IND Clearance of STI-1558, An Oral M(pro) and Cathepsin L Inhibitor to Treat COVID-19 Read more
Avista Therapeutics Partners with Roche to Develop Next-Generation AAV Gene Therapy Vectors for Ocular Diseases Read more
Gilead Sciences Signs New Joint Procurement Agreement with the European Commission for Veklury (Remdesivir) Read more
Nabriva Therapeutics Expands XENLETA (lefamulin) Presence with Exclusive Agreement with Er-Kim Pharmaceuticals Read more